A Rare Event, Scientific Close Calls and a Mishmash from 2004 at the Golden State's Stem Cell Program

Plus "on the fence about people on the fence" -- Ysabel Duron, CIRM director

Apr 21, 2022

∙ Paid

A black swan event: Last Tuesday’s CIRM action on an application for $4 million.

It is not often that the $12 billion California stem cell agency breaks from its more than 17-year-old, decision-making mold. But it did so this week.

In a rare action on Tuesday, the agency’s directors rejected a $4 million proposal that had been approved by both the agency…

Keep reading with a 7-day free trial

Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.